Position in ZTS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$13,712,241
New position
Shares Held
115,999
first reported quarter
Ownership
0.028%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 94.72495452547005.ToString("F0")%
Shared 0.ToString("F0")%
None 5.275045474529953.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Eurizon Capital SGR S.p.A. holds $23,068,987 across 11 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (59.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
115,999 | $13,712,241 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,657 | $3,947,467 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
18,529 | $2,441,010 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
73,891 | $2,225,596 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
12,408 | $296,923 | |
| 6 | VTRS |
Viatris Inc
|
12,313 | $166,348 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
1,419 | $107,631 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,783 | $84,825 |
All Filings in ZTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,712,241 | 115,999 | Shares | Other | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||